Sec Form 13D Filing - Oxus Capital PTE. LTD. filing for - 2026-05-29

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D



Comment for Type of Reporting Person:
(1) Includes 5,302,477 common shares, par value $0.0001 per share ("Common Shares"), of Borealis Foods Inc. (the "Issuer") and 8,469,642 Common Shares underlying private placement warrants (the "Private Warrants") which are each exercisable to purchase a Common Share at $11.50 per share, held directly by Oxus Capital PTE. LTD. ("Oxus Capital") and indirectly beneficially owned by Kenges Rakishev, who is the controlling shareholder of Oxus Capital. As a result, Mr. Rakishev may be deemed to have beneficial ownership of the securities directly held by Oxus Capital. Mr. Rakishev disclaims any beneficial ownership of the shares held by Oxus Capital, except to the extent of his pecuniary interest therein. The Common Shares issuable to Oxus Capital upon automatic conversion of the Indebtedness pursuant to the Conversion Agreement are not included in the beneficial ownership figures reported herein. As of the date of this Amendment, the actual number of Conversion Shares issuable upon conversion cannot be determined because the conversion price is equal to the volume weighted average closing price of the Common Shares on the Nasdaq Stock Market for the twenty (20) consecutive trading days ending on and including the trading day immediately preceding the Equity Raise Deadline, as reported by Bloomberg L.P., which price has not yet been determined. The Reporting Persons will amend this Schedule 13D as required to reflect the final number of Conversion Shares that will be issued upon conversion following the definitive calculation of the conversion price. (2) Based on the sum of 21,463,306 Common Shares outstanding, as reported by the Issuer in its Current Report on Form 10-Q filed on November 19, 2025 and 8,469,642 Common Shares underlying the Private Warrants.


SCHEDULE 13D



Comment for Type of Reporting Person:
(1) Represents 13,772,119 Common Shares of the Issuer and 8,469,642 Common Shares underlying the Private Warrants held directly by Oxus Capital and indirectly beneficially owned by Kenges Rakishev, who is the controlling shareholder of Oxus Capital. As a result, Mr. Rakishev may be deemed to have beneficial ownership of the securities directly held by Oxus Capital. Mr. Rakishev disclaims any beneficial ownership of the shares held by Oxus Capital, except to the extent of his pecuniary interest therein. The Common Shares issuable to Oxus Capital upon automatic conversion of the Indebtedness pursuant to the Conversion Agreement are not included in the beneficial ownership figures reported herein. As of the date of this Amendment, the actual number of Conversion Shares issuable upon conversion cannot be determined because the conversion price is equal to the volume weighted average closing price of the Common Shares on the Nasdaq Stock Market for the twenty (20) consecutive trading days ending on and including the trading day immediately preceding the Equity Raise Deadline, as reported by Bloomberg L.P., which price has not yet been determined. The Reporting Persons will amend this Schedule 13D as required to reflect the final number of Conversion Shares that will be issued upon conversion following the definitive calculation of the conversion price. (2) Based on the sum of 21,463,306 Common Shares outstanding, as reported by the Issuer in its Current Report on Form 10-Q filed on November 19, 2025 and 8,469,642 Common Shares underlying the Private Warrants.


SCHEDULE 13D

 
Oxus Capital PTE. LTD.
 
Signature:/s/ Pavel Mynzhanov, Authorized Signatory
Name/Title:Pavel Mynzhanov
Date:05/29/2026
 
Kenges Rakishev
 
Signature:/s/ Kenges Rakishev
Name/Title:Kenges Rakishev
Date:05/29/2026
primary_doc.xml